Algorae Pharmaceuticals's quarterly market cap
increased
from Dec. 2022 ($11.00 Mil) to Jun. 2023 ($14.35 Mil) but then
declined
from Jun. 2023 ($14.35 Mil) to Dec. 2023 ($12.65 Mil).
Algorae Pharmaceuticals's annual market cap
increased
from Jun. 2021 ($5.35 Mil) to Jun. 2022 ($9.11 Mil) and
increased
from Jun. 2022 ($9.11 Mil) to Jun. 2023 ($14.35 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Algorae Pharmaceuticals's Enterprise Value for Today is $10.52 Mil.
Algorae Pharmaceuticals Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Algorae Pharmaceuticals's Market Cap
For the Biotechnology subindustry, Algorae Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Algorae Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Algorae Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Algorae Pharmaceuticals's Market Cap falls into.
Algorae Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Algorae Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Algorae Pharmaceuticals (OTCPK:LVCLF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Algorae Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of Algorae Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Algorae Pharmaceuticals (Algorae Pharmaceuticals) Business Description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LVCLF has been successfully added to your 